0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Newborn and child health national and provincial clinical practice guidelines in South Africa, Nigeria and Malawi: a scoping review

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Low and middle-income countries remain disproportionately affected by high rates of child mortality. Clinical practice guidelines are essential clinical tools supporting implementation of effective, safe, and cost-effective healthcare. High-quality evidence-based guidelines play a key role in improving clinical management to impact child mortality. We aimed to identify and assess the quality of guidelines for newborn and child health published in South Africa, Nigeria and Malawi in the last 5 years (2017–2022).

          Methods

          We searched relevant websites (June–July 2022), for publicly available national and subnational de novo or adapted guidelines, addressing newborn and child health in the three countries. Pairs of reviewers independently extracted information from eligible guidelines (scope, topic, target population and users, responsible developers, stakeholder consultation process, adaptation description, assessment of evidence certainty). We appraised guideline quality using the Appraisal of Guidelines for Research & Evaluation (AGREE II) instrument.

          Results

          We identified 40-guidelines from the three countries. Of these, 8/40 reported being adopted from a parent guideline. More guidelines ( n = 19) provided guidance on communicable diseases than on non-communicable diseases ( n = 8). Guidelines were most often developed by national health ministries ( n = 30) and professional societies ( n = 14). Eighteen guidelines reported on stakeholder consultation; with Nigeria (10/11) and Malawi (3/6) faring better than South Africa (5/23) in reporting this activity. The Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach was used in 1/7 guidelines that reported assessing certainty of evidence. Overall guidelines scored well on two AGREE II domains: scope and purpose median (IQR) score 68% (IQR 47–83), and clarity of presentation 81% (67–94). Domains critical for ensuring credible guidance scored below 20%: rigour of development 11% (4–32) and editorial independence 6% (0–27).

          Conclusion

          National ministries and professional societies drive guideline activities in Malawi, Nigeria and South Arica. However, the methods and reporting do not adhere to global standards. We found low AGREE II scores for rigour of guideline development and editorial independence and limited use of GRADE or adaptation methods. This undermines the credibility of available guidelines to support evidence-informed care. Our findings highlight the importance of ongoing efforts to strengthen partnerships, capacity, and support for guideline development.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12913-024-10682-0.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

          Scoping reviews, a type of knowledge synthesis, follow a systematic approach to map evidence on a topic and identify main concepts, theories, sources, and knowledge gaps. Although more scoping reviews are being done, their methodological and reporting quality need improvement. This document presents the PRISMA-ScR (Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews) checklist and explanation. The checklist was developed by a 24-member expert panel and 2 research leads following published guidance from the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. The final checklist contains 20 essential reporting items and 2 optional items. The authors provide a rationale and an example of good reporting for each item. The intent of the PRISMA-ScR is to help readers (including researchers, publishers, commissioners, policymakers, health care providers, guideline developers, and patients or consumers) develop a greater understanding of relevant terminology, core concepts, and key items to report for scoping reviews.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            AGREE II: advancing guideline development, reporting and evaluation in health care.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines

              AGREE II is a widely used standard for assessing the methodological quality of practice guidelines. This article describes the development of the AGREE Reporting Checklist, which was designed to improve the quality of practice guideline reporting and aligns with AGREE II in its structure and content.
                Bookmark

                Author and article information

                Contributors
                tamara.kredo@mrc.ac.za
                Journal
                BMC Health Serv Res
                BMC Health Serv Res
                BMC Health Services Research
                BioMed Central (London )
                1472-6963
                19 February 2024
                19 February 2024
                2024
                : 24
                : 221
                Affiliations
                [1 ]Health Systems Research Unit, South African Medical Research Council, ( https://ror.org/05q60vz69) Cape Town, South Africa
                [2 ]GRID grid.517969.5, Evidence Informed Decision-Making Centre, Department of Community and Environmental Health, School of Global and Public Health, , Kamuzu University of Health Sciences, ; Lilongwe, Malawi
                [3 ]Cochrane Nigeria, University of Calabar Teaching Hospital, ( https://ror.org/05qderh61) Calabar, Nigeria
                [4 ]Centre for Evidence-Based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, ( https://ror.org/05bk57929) Cape Town, South Africa
                [5 ]Department of Health Sciences Ålesund, Norwegian University of Science and Technology (NTNU), ( https://ror.org/05xg72x27) Trondheim, Norway
                [6 ]Department of Paediatrics, University of Calabar, ( https://ror.org/05qderh61) Calabar, Nigeria
                [7 ]MAGIC Evidence Ecosystem Foundation, Oslo, Norway
                [8 ]GRID grid.416137.6, ISNI 0000 0004 0627 3157, Department of Medicine, , Lovisenberg Diaconal Hospital, ; Oslo, Norway
                [9 ]Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, ( https://ror.org/05bk57929) Cape Town, South Africa
                [10 ]Department of Internal Medicine, University of Calabar, ( https://ror.org/05qderh61) Calabar, Nigeria
                Article
                10682
                10.1186/s12913-024-10682-0
                10877834
                38374031
                26b4cc41-8897-4b70-8955-5ba1e677fda1
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 26 March 2023
                : 5 February 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001713, European and Developing Countries Clinical Trials Partnership;
                Award ID: RIA2020S-3303-GELA
                Categories
                Research
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2024

                Health & Social care
                clinical practice guidelines,newborn and child health,nigeria,south africa,malawi,scoping review,quality appraisal,grade

                Comments

                Comment on this article